Cite
Central venous access related adverse events after trabectedin infusions in soft tissue sarcoma patients; experience and management in a nationwide multi-center study
MLA
Verboom, M. C., et al. “Central Venous Access Related Adverse Events after Trabectedin Infusions in Soft Tissue Sarcoma Patients; Experience and Management in a Nationwide Multi-Center Study.” Clinical Sarcoma Research, 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1284094309&authtype=sso&custid=ns315887.
APA
Verboom, M. C., Ouwerkerk, J., Steeghs, N., Lutjeboer, J., Kerst, J. M., Graaf, W. T. A. van der, Reyners, A. K., Sleijfer, S., & Gelderblom, H. (2017). Central venous access related adverse events after trabectedin infusions in soft tissue sarcoma patients; experience and management in a nationwide multi-center study. Clinical Sarcoma Research.
Chicago
Verboom, M.C., J. Ouwerkerk, N. Steeghs, J. Lutjeboer, J.M. Kerst, W.T.A. van der Graaf, A.K. Reyners, S. Sleijfer, and H. Gelderblom. 2017. “Central Venous Access Related Adverse Events after Trabectedin Infusions in Soft Tissue Sarcoma Patients; Experience and Management in a Nationwide Multi-Center Study.” Clinical Sarcoma Research. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1284094309&authtype=sso&custid=ns315887.